General Information of This Metabolic Reaction (MR) (ID:
MR009236) |
Formula |
|
Reactant |
Ingrezza |
Product |
(+)-alpha-HTBZ |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Esterases (ES)
|
DME Info
|
Metabolic Type
|
Hydrolysis
-
Hydrolysis
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites J Pharmacol Exp Ther. 2017 Jun;361(3):454-461. doi: 10.1124/jpet.116.239160.
|
2 |
VMAT2 Inhibitors in Neuropsychiatric Disorders
|
3 |
DrugBank(Pharmacology-Metabolism):Tetrabenazine
|
4 |
Pharmacokinetic and Pharmacologic Characterization of the Dihydrotetrabenazine Isomers of Deutetrabenazine and Valbenazine. Clin Pharmacol Drug Dev. 2023 Apr;12(4):447-456. doi: 10.1002/cpdd.1205.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.